ライフサイエンスコーパス: osteoid osteoma

1 increase significantly at needle puncture of osteoid osteoma.

2 d by anti-inflammatory drugs may point to an osteoid osteoma.

3 t of a routine strategy for the treatment of osteoid osteoma.

4 intraarticular (69% in paediatric patients) osteoid-osteoma.

5 ndings that were diagnostic for nonvertebral osteoid osteoma and no contraindications to MR imaging-g

6 se, lower extremity injuries in toddlers and osteoid osteoma are emphasized.

7 y ablation is now the standard treatment for osteoid osteoma, as the procedure can be performed with

8 ef and the other experienced a recurrence of osteoid osteoma at 11 months, which was successfully tre

9 ale; mean age, 21 years) with a diagnosis of osteoid osteoma based on clinical and imaging findings.

10 CT-guided cryoablation for the treatment of osteoid osteoma between January 2013 and June 2019 in a

11 at MR-guided focused ultrasound treatment of osteoid osteoma can be performed safely with a high rate

12 Osteoid osteomas can be imaged with greater conspicuity

13 Osteoid osteoma characteristics, procedure overview, and

14 six patients with histopathologically proven osteoid osteomas, complete clinical files, and CT data w

15 Diaphyseal osteoid osteomas demonstrate a lower ratio of nidus mine

16 MR imaging features of osteoid osteoma (edema, hyperemia, and nidus vasculariza

17 olinium-enhanced MR imaging demonstrated the osteoid osteoma equally well in eight of 11 patients and

18 compass enchondromas, aneurysmal bone cysts, osteoid osteomas, giant-cell lesions of bone, bone sarco

19 ing, the edema and hyperemia associated with osteoid osteoma gradually disappeared in all lesions.

20 One osteoid osteoma had peak enhancement in the venous phase

21 Biopsy results revealed osteoid osteoma in 10 patients, chondroblastoma in one,

22 monstrate secondary radiological findings of osteoid osteoma in both paediatric and adult patients.

23 rable treatment option for the management of osteoid osteoma in children and young adults.

24 Of the 97 patients who had osteoid osteoma in lower extremities or pelvic bones, 73

25 bone location, bone segment, location of the osteoid osteoma in relation to the native cortex, nidus

26 ) of 11 patients had peak enhancement of the osteoid osteoma in the arterial phase with early partial

27 CT-guided cryoablation for the treatment of osteoid osteoma in young patients and adults.

28 The nidus mineralization ratio of osteoid osteomas increases significantly with pain durat

29 CT-guided percutaneous RF ablation of osteoid osteoma is a safe and effective technique.

30 Diagnosis of osteoid osteoma may be delayed if secondary radiological

31 ded radiofrequency ablation [RA] therapy for osteoid osteoma (OO).

32 wever, in the 10 patients with biopsy-proved osteoid osteoma, puncture of the tumor caused the mean c

33 echniques were scored for conspicuity of the osteoid osteoma relative to the surrounding bone.

34 dolinium-enhanced MR images demonstrated the osteoid osteomas significantly better than the nonenhanc

35 ve and should become the method of choice in osteoid osteoma treatment because of its minimal invasiv

36 f cryoablation have not been established for osteoid osteoma treatment.

37 d, 263 patients who were suspected of having osteoid osteoma underwent 271 ablation procedures.

38 In 89.4% of these, osteoid osteoma was localised in the joint.

39 Conclusion Osteoid osteoma was safely, effectively, and durably tre

40 ion (ILA) on the management of patients with osteoid osteoma was studied.

41 Consecutive patients with osteoid osteoma were assessed before the interventional

42 6% of tumours were intracortical, and 83% of osteoid osteomas were extra-articular.

43 Eighty-three per cent of osteoid osteomas were located in lower extremities, 56%

44 In long bones, diaphyseal osteoid osteomas were significantly less mineralized tha

45 es of 11 patients with pathologically proven osteoid osteomas who underwent nonenhanced MR imaging, d

46 CT-guided cryoablation for the treatment of osteoid osteoma, with a 96% (48 of 50 patients) overall